Trial Profile
A Retrospective study to evaluate Ospemifene for the prevention of recurrent lower urinary tract infections in postmenopausal women with Atrophic-vaginitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Sep 2018
Price :
$35
*
At a glance
- Drugs Ospemifene (Primary)
- Indications Atrophic vaginitis
- Focus Adverse reactions; Therapeutic Use
- 05 Sep 2018 New trial record